Home LiteratureArticle Details
PMID: 11189688 Published · ppublish English Journal Article

Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.

Controlled clinical trials ·Vol. 21 ·No. 6 Suppl ·2000-12-00 ·Pages 356S-378S

Simpson NK, Johnson CC, Ogden SL, Gamito E, Trocky N, McGuire C, Martin J, Barrow S, Lamerato L, Flickinger LM, Broski KG, Engelhard D, Hilke C, Bonk J, Gahagan B, Gren LH, Childs J, Lappe K, Fouad M, Thompson J, Sullivan D, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team

Abstract

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial has a total enrollment goal of almost 150,000 participants. These participants are being recruited at ten screening centers across the United States. All screening centers tested recruitment methodologies during a 1-year pilot phase. The main phase of recruitment was planned to take place over a 3-year period. The majority of participants are being recruited during the main phase of the study. Each of the screening centers tailors recruitment to its individual catchment area. Recruitment strategies in the PLCO trial are described. As the trial began, several protocol changes were made to help to increase enrollment. The National Cancer Institute (NCI) initiated recruitment efforts at the national level. The individual screening centers describe some of the specific recruitment experiences encountered. As the study progressed, the NCI implemented special initiatives to increase the enrollment of minority participants.

MeSH Terms
Aged Colorectal Neoplasms/diagnosis,prevention & control Female Humans Lung Neoplasms/diagnosis,prevention & control Male Mass Screening Middle Aged Multicenter Studies as Topic Ovarian Neoplasms/diagnosis,prevention & control Patient Selection Prostatic Neoplasms/diagnosis,prevention & control Randomized Controlled Trials as Topic
Authors & Affiliations
22 authors, click to expand affiliations / ORCID
Simpson N K
Early Detection Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland 20892-7346, USA.
Johnson C C
Ogden S L
Gamito E
Trocky N
McGuire C
Martin J
Barrow S
Lamerato L
Flickinger L M
Broski K G
Engelhard D
Hilke C
Bonk J
Gahagan B
Gren L H
Childs J
Lappe K
Fouad M
Thompson J
Sullivan D
Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Article Info
Journal
Controlled clinical trials
Abbr.
Control Clin Trials
ISSN
0197-2456
Published
2000-12-00
Pages
356S-378S
Language
English
Region
United States
NLM ID
8006242
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]